Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Küpfer

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1980
Identification of mephenytoin metabolites in the dogG Karlaganis, A Küpfer, J Bircher, et al.
British Journal of Pharmacology|January 1, 1990
Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?M Pirovino, U Honegger, O Müller, et al.
Free Radical Research|November 11, 2010
An assay for RNA oxidation induced abasic sites using the Aldehyde Reactive ProbeMikiei Tanaka, Song Han, Han Song, et al.
Biochemical Pharmacology|October 15, 1982
Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strainsA Küpfer, S G Al-Dabbagh, J C Ritchie, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyT Cerny, G Martinelli, A Goldhirsch, et al.
Free Radical Biology & Medicine|June 12, 2012
RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondriaMikiei Tanaka, Pawel Jaruga, Pascal A Küpfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1980
Identification of mephenytoin metabolites in the dogG Karlaganis, A Küpfer, J Bircher, et al.
British Journal of Pharmacology|January 1, 1990
Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?M Pirovino, U Honegger, O Müller, et al.
Free Radical Research|November 11, 2010
An assay for RNA oxidation induced abasic sites using the Aldehyde Reactive ProbeMikiei Tanaka, Song Han, Han Song, et al.
Biochemical Pharmacology|October 15, 1982
Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strainsA Küpfer, S G Al-Dabbagh, J C Ritchie, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyT Cerny, G Martinelli, A Goldhirsch, et al.
Free Radical Biology & Medicine|June 12, 2012
RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondriaMikiei Tanaka, Pawel Jaruga, Pascal A Küpfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Pageof 6